• Publications
  • Influence
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.
TLDR
Following guidelines for TDM in psychiatry will help to improve the outcomes of psychopharmacotherapy of many patients especially in case of pharmacokinetic problems, and one should never forget that TDM is an interdisciplinary task that sometimes requires the respectful discussion of apparently discrepant data. Expand
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
TLDR
Following the new guidelines for therapeutic drug monitoring in psychiatry holds the potential to improve neuropsychopharmacotherapy, accelerate the recovery of many patients, and reduce health care costs. Expand
The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
Therapeutic Drug Monitoring (TDM) is a valid tool to optimise pharmacotherapy. It enables the clinician to adjust the dosage of drugs according to the characteristics of the individual patient. InExpand
MAO-inhibitors in Parkinson's Disease
TLDR
In general, the clinical use of MAO-I nowadays is underestimated and there should be more efforts to evaluate their clinical potency as antidepressants and antidementive drugs in addition to the final proof of their disease-modifying potential. Expand
Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project.
TLDR
The poorer treatment outcome in patients with anxious depression demonstrates the need to address the issue of specific treatment strategies for this subgroup, and anxious depression has no moderating effect on the efficacy of algorithm-guided treatment. Expand
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.
TLDR
Following guidelines for TDM in psychiatry will help to improve the outcomes of psychopharmacotherapy of many patients especially in case of pharmacokinetic problems, and one should never forget that TDM is an interdisciplinary task that sometimes requires the respectful discussion of apparently discrepant data. Expand
Response and remission criteria in major depression--a validation of current practice.
TLDR
The authors' data largely confirmed currently used remission and response criteria in naturalistically treated patients as well as comparing the validity of different HAMD, MADRS and BDI cut-offs. Expand
Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders
TLDR
A significant association was found between functional remission and symptomatic resolution, indicating reasonable validity of the proposed definition for functional outcome. Expand
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
TLDR
Authors C. Hiemke, N. Bergemann, H. Zurek, and G. Baumann write about life in the post-war period and the aftermath of the Second World War, as well as some of the events leading up to and during the conflict. Expand
One-year functional outcomes of naturalistically treated patients with schizophrenia
TLDR
A significant association was found between functional and symptomatic remission at discharge and at the 1-year follow-up visit and the strongest predictors for functional remission were: a higher SCPS total score at admission, a lower number of previous hospitalizations, a status of employment, lower scores in all PANSS subscales at discharge, and female gender. Expand
...
1
2
3
4
5
...